mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.28 |
0.3 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.4 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |